Back to Search Start Over

Correction: Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab.

Authors :
Joseph RW
Elassaiss-Schaap J
Kefford R
Hwu WJ
Wolchok JD
Joshua AM
Ribas A
Hodi FS
Hamid O
Robert C
Daud A
Dronca R
Hersey P
Weber JS
Patnaik A
de Alwis DP
Perrone A
Zhang J
Kang SP
Ebbinghaus S
Anderson KM
Gangadhar TC
Source :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Dec 01; Vol. 24 (23), pp. 6098.
Publication Year :
2018

Details

Language :
English
ISSN :
1557-3265
Volume :
24
Issue :
23
Database :
MEDLINE
Journal :
Clinical cancer research : an official journal of the American Association for Cancer Research
Publication Type :
Academic Journal
Accession number :
30510087
Full Text :
https://doi.org/10.1158/1078-0432.CCR-18-3340